adamantane has been researched along with globotriaosylceramide in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lingwood, CA; Mylvaganam, M | 1 |
| Fantini, J; Lingwood, CA; Mahfoud, R; Mylvaganam, M | 1 |
| Binnington, B; Blumenthal, R; Branch, DR; Chark, D; Fantini, J; Lingwood, CA; Lund, N; Ma, XZ; Mylvaganam, M; Puri, A; Sakac, D | 1 |
| Ackerley, C; Clarke, DM; De Rosa, MF; Ito, S; Lingwood, C; Wang, B | 1 |
| Binnington, B; Lingwood, C; Mylvaganum, M; Novak, A; Saito, M; Tam, P | 1 |
5 other study(ies) available for adamantane and globotriaosylceramide
| Article | Year |
|---|---|
Adamantyl globotriaosyl ceramide: a monovalent soluble mimic which inhibits verotoxin binding to its glycolipid receptor.
Topics: Adamantane; Bacterial Toxins; Binding Sites; Chromatography, Thin Layer; Drug Design; Glycolipids; Inhibitory Concentration 50; Mass Spectrometry; Molecular Mimicry; Protein Binding; Receptors, Cell Surface; Shiga Toxin 1; Solubility; Trihexosylceramides; Water | 1999 |
A novel soluble analog of the HIV-1 fusion cofactor, globotriaosylceramide (Gb(3)), eliminates the cholesterol requirement for high affinity gp120/Gb(3) interaction.
Topics: Adamantane; Animals; Cattle; Centrifugation, Density Gradient; Cholesterol; Erythrocytes; HIV Envelope Protein gp120; Humans; Lipids; Models, Structural; Pressure; Protein Binding; Protein Structure, Tertiary; Serum Albumin, Bovine; Solubility; Substrate Specificity; Sulfoglycosphingolipids; Surface Tension; Trihexosylceramides | 2002 |
A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection.
Topics: Adamantane; Antiviral Agents; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Glycolipids; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Jurkat Cells; Leukocytes, Mononuclear; Microscopy, Electron; Trihexosylceramides | 2006 |
Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
Topics: Adamantane; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Calcium Channel Blockers; Cell Membrane; Cell Polarity; Cyclosporine; Dogs; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endocytosis; Enzyme Inhibitors; Fluorescent Dyes; Golgi Apparatus; Humans; Intestinal Mucosa; Neoplasms; Protein Binding; Protein Structure, Secondary; Protein Synthesis Inhibitors; Protein Transport; Rhodamine 123; Shiga Toxins; Time Factors; Trihexosylceramides; Up-Regulation; Verapamil; Vinblastine | 2008 |
Structure-dependent pseudoreceptor intracellular traffic of adamantyl globotriaosyl ceramide mimics.
Topics: Adamantane; Animals; Biological Transport, Active; Cell Membrane; Chlorocebus aethiops; CHO Cells; Cholesterol; Cricetinae; Cricetulus; Endoplasmic Reticulum; Endosomes; HEK293 Cells; Humans; Shiga Toxin 1; Shiga Toxin 2; Structure-Activity Relationship; Trihexosylceramides; Vero Cells | 2012 |